Ventolinhfa
Product Images NDC 21695-423

11 FDA label images from Rebel Distributors Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ventolinhfa (NDC 21695-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ventolin Container Label (423)

Ventolin Container Label (423)
The image shows a product label for VENTOLINHFA HFA 90mcg 8gm inhaler, labeled by Rebel Distributors Corp. The label includes the NDC 21695-423 with information indicating it is for prescription use (RX Only). Distributor details for Physician Partners in Thousand Oaks, CA are provided along with storage and safety instructions.*
FDA Label Image

Albuterol Sulfate Chemical Structure (55650e7d F04f 47f1 92ea 593ea409530a 01)

Albuterol Sulfate Chemical Structure (55650e7d F04f 47f1 92ea 593ea409530a 01)
Chemical structure diagram depicting the active ingredient of VENTOLINHFA HFA. The structural formula illustrates a complex molecule with hydroxyl groups and sulfuric acid as indicated by the chemical notation.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Day 1)
A line graph comparing the mean percent change from baseline over time (in hours) for three inhaler treatments: CFC 11/12-propelled albuterol, VENTOLIN HFA, and HFA-134a placebo inhaler. The graph shows data points from 0 to 6 hours on the x-axis and percent change on the y-axis, illustrating the efficacy profile of these treatments over time.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial (Week 12)
A line chart comparing mean percentage change from baseline in FEV1 over time (hours) after administration of different inhalers: CFC 11/12-propelled albuterol, VENTOLIN HFA, and HFA-134a placebo inhaler, each with varying inhalation frequencies and subject counts. The y-axis represents mean % change from baseline, and the x-axis represents time in hours.*
FDA Label Image

Figure 1 (55650e7d F04f 47f1 92ea 593ea409530a 04)

Figure 1 (55650e7d F04f 47f1 92ea 593ea409530a 04)
An instructional line drawing depicting a Ventolin HFA metered-dose inhaler with labeled parts including the metal canister, plastic actuator, mouthpiece, cap, strap, and dose counter.*
FDA Label Image

Figure 2 (55650e7d F04f 47f1 92ea 593ea409530a 05)

Figure 2 (55650e7d F04f 47f1 92ea 593ea409530a 05)
An instructional illustration showing how to hold an inhaler in the mouthpiece-down position. It highlights the mouthpiece, strap, and cap components of the inhaler device, demonstrating proper handling technique for use.*
FDA Label Image

Figure 3 (55650e7d F04f 47f1 92ea 593ea409530a 06)

Figure 3 (55650e7d F04f 47f1 92ea 593ea409530a 06)
An instructional illustration showing a person holding a VENTOLINHFA HFA inhaler near their mouth. The image includes an arrow and text that reads 'Push down and breathe in,' demonstrating the correct use of the inhaler.*
FDA Label Image

Figure 4 (55650e7d F04f 47f1 92ea 593ea409530a 07)

Figure 4 (55650e7d F04f 47f1 92ea 593ea409530a 07)
An instructional illustration showing a hand holding a canister above a sink, demonstrating how to properly clean or rinse the metal canister of a VENTOLINHFA HFA inhaler under running water. Another inhaler canister is resting on the sink surface.*
FDA Label Image

Figure 5 (55650e7d F04f 47f1 92ea 593ea409530a 08)

Figure 5 (55650e7d F04f 47f1 92ea 593ea409530a 08)
An instructional illustration showing a hand holding a VENTOLINHFA HFA inhaler with water running from a faucet over the inhaler mouthpiece. The inhaler is positioned to be rinsed under the running water, indicating a cleansing step for the device.*
FDA Label Image

Figure 6 (55650e7d F04f 47f1 92ea 593ea409530a 09)

Figure 6 (55650e7d F04f 47f1 92ea 593ea409530a 09)
An instructional illustration divided into two sections: the top section shows an inhaler being used with a person exhaling, and the bottom section depicts three inhalers in different positions, demonstrating steps of use or assembly. This likely relates to proper inhaler technique.*
FDA Label Image

Figure 7 (55650e7d F04f 47f1 92ea 593ea409530a 10)

Figure 7 (55650e7d F04f 47f1 92ea 593ea409530a 10)
An instructional illustration showing the correct and incorrect ways to use the VENTOLINHFA HFA inhaler. The top image demonstrates an unblocked inhaler with medication spray exiting properly, while the bottom image shows a blocked inhaler with the spray obstructed by the user's finger placement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.